Report presenting the National Security Commission on Artificial Intelligence's initial (NSCAI)'s preliminary assessment of artificial intelligence (AI). It discusses NSCAI's definition of AI, the challenges and context around it, where the U.S. Government can apply it, considerations on ethical and trustworhy AI, and associated technologies.

A brief report summarizing the National Security Commission on Artificial Intelligence's activities, meetings, relationships with the U.S. Government, industry, and academia, early substantive assessments, commission staff, and next steps.

This report discuses research and development of artificial intelligence (AI) applications for the military, their potential uses, and the programs of competing nations such as China and Russia.

This report discusses artificial intelligence in education, including current applications, benefits and drawbacks, and policy considerations.

Report representing the results of a Comptroller General forum on recent developments in the area of artificial intelligence (AI) - and key implications regarding potential benefits, challenges to realizing these benefits, and resulting policy implications and research priorities.

Statement discussing the evolution of artificial intelligence (AI) over time, the potential future opportunities and risks of AI, and the future implications of AI on policies and research priorities.

Artificial intelligence and machine learning (AI/ML) is a set of technologies that includes automated systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, and decision-making. AI/ML has promising applications in health care, including drug development. For example, it may have the potential to help identify new treatments, reduce failure rates in clinical trials, and generally result in a more efficient and effective drug development process. However, applying AI/ML technologies within the health care system also raises ethical, legal, economic, and social questions. GAO was asked to conduct a technology assessment on the use of AI technologies in drug development with an emphasis on foresight and policy implications. This report discusses (1) current and emerging AI technologies available for drug development and their potential benefits; (2) challenges to the development and adoption of these technologies; and (3) policy options to address challenges to the use of machine learning in drug development. -- from Foreword

Report studying potential human rights issues that could arise from the everyday use of artificial intelligence (AI).

Report detailing the discussion in a meeting of experts and representatives from international organizations on the topic of ethical concerns of using Big Data and Artificial Intelligence (AI) in healthcare. Includes a list of participants and the meeting's agenda.